GeneFerm Biotechnology Co., Ltd. (1796.TWO)

TWD 46.65

(0.43%)

Operating Income Summary of GeneFerm Biotechnology Co., Ltd.

  • GeneFerm Biotechnology Co., Ltd.'s latest annual operating income in 2023 was 153.56 Million TWD , up 38.71% from previous year.
  • GeneFerm Biotechnology Co., Ltd.'s latest quarterly operating income in 2024 Q2 was -7.96 Million TWD , down -19.69% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported an annual operating income of 113.31 Million TWD in 2022, up 43.16% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported an annual operating income of 79.15 Million TWD in 2021, up 351.8% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported a quarterly operating income of -7.96 Million TWD for 2024 Q2, down -19.69% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported a quarterly operating income of 61.23 Million TWD for 2023 Q2, up 58.28% from previous quarter.

Annual Operating Income Chart of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Created with Highcharts 11.1.0YearsOperating Income20192019.520202020.520212021.520222022.52023-50000000 TWD0 TWD50000000 TWD100000000 TWD150000000 TWD200000000 TWD

Historical Annual Operating Income of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 153.56 Million TWD 38.71%
2022 113.31 Million TWD 43.16%
2021 79.15 Million TWD 351.8%
2020 17.51 Million TWD 174.94%
2019 -23.37 Million TWD 0.0%

Peer Operating Income Comparison of GeneFerm Biotechnology Co., Ltd.

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD -73.101%
Easywell Biomedicals, Inc. -162.73 Million TWD 194.363%
TTY Biopharm Company Limited 1.37 Billion TWD 88.811%
Synmosa Biopharma Corporation 614.74 Million TWD 75.02%
Orient EuroPharma Co., Ltd. 84.55 Million TWD -81.618%
Center Laboratories, Inc. -79.26 Million TWD 293.736%
Tien Liang BioTech Co., Ltd. 20.43 Million TWD -651.444%
Orient Pharma Co., Ltd. 27.75 Million TWD -453.328%
InnoPharmax Inc. -64.83 Million TWD 336.84%
Johnson Chemical Pharmaceutical Works Co., Ltd. 105.57 Million TWD -45.461%
Excelsior Biopharma Inc. -81.12 Million TWD 289.287%
DV Biomed Co., Ltd. 173.54 Million TWD 11.515%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 115.24%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 77.93%
UniPharma Co., Ltd. -27.3 Million TWD 662.406%
Anxo Pharmaceutical Co., Ltd. 53.15 Million TWD -188.911%
Alar Pharmaceuticals Inc. 385.52 Million TWD 60.168%
Winston Medical Supply Co., Ltd. 196.1 Million TWD 21.691%
Mercury Biopharmaceutical Corporation -45.69 Million TWD 436.102%
Bioray Biotech Co., Ltd -19.33 Million TWD 894.398%
TSH Biopharm Corporation Limited 63.63 Million TWD -141.341%